Skip to main content
Top
Published in: Social Psychiatry and Psychiatric Epidemiology 5/2020

01-05-2020 | Schizophrenia | Original Paper

Maternal schizophrenia and adverse birth outcomes: what mediates the risk?

Authors: Simone N. Vigod, Kinwah Fung, Abigail Amartey, Emily Bartsch, Reema Felemban, Natasha Saunders, Astrid Guttmann, Maria Chiu, Lucy C. Barker, Paul Kurdyak, Hilary K. Brown

Published in: Social Psychiatry and Psychiatric Epidemiology | Issue 5/2020

Login to get access

Abstract

Purpose

Maternal schizophrenia is associated with adverse birth outcomes, but the reasons for this remain unclear. In a population-based cohort of infants born to women with schizophrenia, we determined the occurrence of key perinatal outcomes and explored whether factors identifiable in our datasets explained any elevated risk.

Methods

Using population-level health administrative data linked to clinical birth-registry data in Ontario, Canada (2006–2011), we examined the relative risk (RR) of preterm birth (< 37 weeks), small for gestational age (SGA), and Apgar scores < 8 in infants of women with schizophrenia (n = 4279) versus infants of unaffected women (n = 286,147). Generalized estimating equations determined whether reproductive history, maternal health conditions, pregnancy exposures, and complications explained elevated RRs.

Results

Among infants of women with schizophrenia, risk was higher for prematurity (11.4% vs. 6.9%, aRR 1.64, 95% CI 1.51–1.79), SGA (3.5% vs. 2.5%, aRR 1.40, 95% CI 1.20–1.64), and Apgar score < 8 at 1 (19.0% vs. 12.8%, aRR 1.49, 95% CI 1.40–1.59) and 5 min (5.6% vs. 3.0%, aRR 1.90, 95% CI 1.68–2.16). Smoking, fourfold more common among women with schizophrenia, was the variable that explained the greatest proportion of the elevated aRR for prematurity (9.9%), SGA (28.7%), and Apgar < 8 at 1 and 5 min (9.8%, 5.6%). Illicit substance use, certain reproductive history variables, and pregnancy complications also contributed to the elevated aRR for preterm birth.

Conclusions

Elevated risks of preterm birth, SGA, and low Apgar scores in infants of women with schizophrenia are partly explained by potentially modifiable factors such as smoking and illicit drug use, suggesting opportunities for targeted intervention.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bennedsen BE (1998) Adverse pregnancy outcome in schizophrenic women: occurrence and risk factors. Schizophr Res 33(1–2):1–26PubMed Bennedsen BE (1998) Adverse pregnancy outcome in schizophrenic women: occurrence and risk factors. Schizophr Res 33(1–2):1–26PubMed
2.
go back to reference Conde A et al (2010) Mother’s anxiety and depression and associated risk factors during early pregnancy: effects on fetal growth and activity at 20–22 weeks of gestation. J Psychosom Obstet Gynaecol 31(2):70–82PubMed Conde A et al (2010) Mother’s anxiety and depression and associated risk factors during early pregnancy: effects on fetal growth and activity at 20–22 weeks of gestation. J Psychosom Obstet Gynaecol 31(2):70–82PubMed
3.
go back to reference Judd F et al (2014) Adverse obstetric and neonatal outcomes in women with severe mental illness: to what extent can they be prevented? Schizophr Res 157(1–3):305–309PubMed Judd F et al (2014) Adverse obstetric and neonatal outcomes in women with severe mental illness: to what extent can they be prevented? Schizophr Res 157(1–3):305–309PubMed
4.
go back to reference Vigod SN et al (2012) Temporal trends in general and age-specific fertility rates among women with schizophrenia (1996–2009): a population-based study in Ontario, Canada. Schizophr Res 139(1–3):169–175PubMed Vigod SN et al (2012) Temporal trends in general and age-specific fertility rates among women with schizophrenia (1996–2009): a population-based study in Ontario, Canada. Schizophr Res 139(1–3):169–175PubMed
5.
go back to reference Ng R et al (2015) Brain disorders in Ontario: prevalence, incidence and costs from health administrative data. Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada Ng R et al (2015) Brain disorders in Ontario: prevalence, incidence and costs from health administrative data. Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
6.
go back to reference Lasser K et al (2000) Smoking and mental illness: a population-based prevalence study. JAMA 284(20):2606–2610PubMed Lasser K et al (2000) Smoking and mental illness: a population-based prevalence study. JAMA 284(20):2606–2610PubMed
7.
go back to reference Hudson CG (2005) Socioeconomic status and mental illness: tests of the social causation and selection hypotheses. Am J Orthopsychiatr 75(1):3–18 Hudson CG (2005) Socioeconomic status and mental illness: tests of the social causation and selection hypotheses. Am J Orthopsychiatr 75(1):3–18
8.
go back to reference Lin HC, Chen YH, Lee HC (2009) Prenatal care and adverse pregnancy outcomes among women with schizophrenia: a nationwide population-based study in Taiwan. J Clin Psychiatr 70(9):1297–1303 Lin HC, Chen YH, Lee HC (2009) Prenatal care and adverse pregnancy outcomes among women with schizophrenia: a nationwide population-based study in Taiwan. J Clin Psychiatr 70(9):1297–1303
9.
go back to reference Buss C et al (2012) The Role of stress in brain development: the gestational environment’s long-term effects on the brain. Cerebrum 2012:4PubMedPubMedCentral Buss C et al (2012) The Role of stress in brain development: the gestational environment’s long-term effects on the brain. Cerebrum 2012:4PubMedPubMedCentral
10.
go back to reference Beijers R et al (2010) Maternal prenatal anxiety and stress predict infant illnesses and health complaints. Pediatrics 126(2):e401–e409PubMed Beijers R et al (2010) Maternal prenatal anxiety and stress predict infant illnesses and health complaints. Pediatrics 126(2):e401–e409PubMed
11.
go back to reference Dunkel Schetter C, Tanner L (2012) Anxiety, depression and stress in pregnancy: implications for mothers, children, research, and practice. Curr Opin Psychiatr 25(2):141–148 Dunkel Schetter C, Tanner L (2012) Anxiety, depression and stress in pregnancy: implications for mothers, children, research, and practice. Curr Opin Psychiatr 25(2):141–148
12.
go back to reference Williams J et al (1996) Patterns of health care in Ontario: the ICES Practice Atlas. Canadian Medical Association, Ottawa Williams J et al (1996) Patterns of health care in Ontario: the ICES Practice Atlas. Canadian Medical Association, Ottawa
13.
go back to reference Ray JG et al (2012) Birth weight curves tailored to maternal world region. J Obstet Gynaecol Can 34(2):159–171PubMed Ray JG et al (2012) Birth weight curves tailored to maternal world region. J Obstet Gynaecol Can 34(2):159–171PubMed
14.
go back to reference Kurdyak P et al (2015) Validation of a population-based algorithm to detect chronic psychotic illness. Can J Psychiatr 60(8):362–368 Kurdyak P et al (2015) Validation of a population-based algorithm to detect chronic psychotic illness. Can J Psychiatr 60(8):362–368
15.
go back to reference Razaz N et al (2016) Five-minute Apgar score as a marker for developmental vulnerability at 5 years of age. Arch Dis Child Fetal Neonatal Ed 101(2):F114–F120PubMed Razaz N et al (2016) Five-minute Apgar score as a marker for developmental vulnerability at 5 years of age. Arch Dis Child Fetal Neonatal Ed 101(2):F114–F120PubMed
16.
go back to reference Health Canada, M.o.P.W.a.G.S.C. (2000) Perinatal health indicators for Canada: a resource manual, Ottawa Health Canada, M.o.P.W.a.G.S.C. (2000) Perinatal health indicators for Canada: a resource manual, Ottawa
17.
go back to reference Ehrenstein V et al (2009) Association of Apgar score at 5 min with long-term neurologic disability and cognitive function in a prevalence study of Danish conscripts. BMC Pregnancy Childbirth 9:14PubMedPubMedCentral Ehrenstein V et al (2009) Association of Apgar score at 5 min with long-term neurologic disability and cognitive function in a prevalence study of Danish conscripts. BMC Pregnancy Childbirth 9:14PubMedPubMedCentral
18.
go back to reference Urquia ML et al (2007) Birth outcomes by neighbourhood income and recent immigration in Toronto. Health Rep 18(4):21–30PubMed Urquia ML et al (2007) Birth outcomes by neighbourhood income and recent immigration in Toronto. Health Rep 18(4):21–30PubMed
19.
go back to reference Hux JE et al (2002) Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 25(3):512–516PubMed Hux JE et al (2002) Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 25(3):512–516PubMed
20.
go back to reference Quan H et al (2009) Validation of a case definition to define hypertension using administrative data. Hypertension 54(6):1423–1428PubMed Quan H et al (2009) Validation of a case definition to define hypertension using administrative data. Hypertension 54(6):1423–1428PubMed
21.
go back to reference McCarthy J, Maine D (1992) A framework for analyzing the determinants of maternal mortality. Stud Fam Plann 23(1):23–33PubMed McCarthy J, Maine D (1992) A framework for analyzing the determinants of maternal mortality. Stud Fam Plann 23(1):23–33PubMed
22.
go back to reference Saccone G, Perriera L, Berghella V (2016) Prior uterine evacuation of pregnancy as independent risk factor for preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol 214(5):572–591PubMed Saccone G, Perriera L, Berghella V (2016) Prior uterine evacuation of pregnancy as independent risk factor for preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol 214(5):572–591PubMed
23.
go back to reference Steer P (2005) The epidemiology of preterm labour. BJOG 112(Suppl 1):1–3PubMed Steer P (2005) The epidemiology of preterm labour. BJOG 112(Suppl 1):1–3PubMed
24.
go back to reference Gravett MG et al (2010) Global report on preterm birth and stillbirth (2 of 7): discovery science. BMC Pregnancy Childbirth 10(Suppl 1):S2PubMedPubMedCentral Gravett MG et al (2010) Global report on preterm birth and stillbirth (2 of 7): discovery science. BMC Pregnancy Childbirth 10(Suppl 1):S2PubMedPubMedCentral
25.
go back to reference Sheehan PM et al (2015) Maternal thyroid disease and preterm birth: systematic review and meta-analysis. J Clin Endocrinol Metab 100(11):4325–4331PubMed Sheehan PM et al (2015) Maternal thyroid disease and preterm birth: systematic review and meta-analysis. J Clin Endocrinol Metab 100(11):4325–4331PubMed
26.
go back to reference Aagaard-Tillery KM et al (2008) In utero tobacco exposure is associated with modified effects of maternal factors on fetal growth. Am J Obstet Gynecol 198(1):66.e1–66.e6 Aagaard-Tillery KM et al (2008) In utero tobacco exposure is associated with modified effects of maternal factors on fetal growth. Am J Obstet Gynecol 198(1):66.e1–66.e6
27.
go back to reference Patra J et al (2011) Dose-response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA)-a systematic review and meta-analyses. BJOG 118(12):1411–1421PubMedPubMedCentral Patra J et al (2011) Dose-response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA)-a systematic review and meta-analyses. BJOG 118(12):1411–1421PubMedPubMedCentral
28.
go back to reference Maeda A et al (2014) Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes. Anesthesiology 121(6):1158–1165PubMed Maeda A et al (2014) Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes. Anesthesiology 121(6):1158–1165PubMed
29.
go back to reference Gouin K et al (2011) Effects of cocaine use during pregnancy on low birthweight and preterm birth: systematic review and metaanalyses. Am J Obstet Gynecol 204(4):340.e1–340.e12 Gouin K et al (2011) Effects of cocaine use during pregnancy on low birthweight and preterm birth: systematic review and metaanalyses. Am J Obstet Gynecol 204(4):340.e1–340.e12
30.
go back to reference Gorman MC et al (2014) Outcomes in pregnancies complicated by methamphetamine use. Am J Obstet Gynecol 211(4):429.e1–429.e7 Gorman MC et al (2014) Outcomes in pregnancies complicated by methamphetamine use. Am J Obstet Gynecol 211(4):429.e1–429.e7
31.
go back to reference Hingson R et al (1982) Maternal cigarette smoking, psychoactive substance use, and infant Apgar scores. Am J Obstet Gynecol 144(8):959–966PubMed Hingson R et al (1982) Maternal cigarette smoking, psychoactive substance use, and infant Apgar scores. Am J Obstet Gynecol 144(8):959–966PubMed
32.
go back to reference Vahanian SA et al (2015) Placental implantation abnormalities and risk of preterm delivery: a systematic review and metaanalysis. Am J Obstet Gynecol 213(4 Suppl):S78–S90PubMed Vahanian SA et al (2015) Placental implantation abnormalities and risk of preterm delivery: a systematic review and metaanalysis. Am J Obstet Gynecol 213(4 Suppl):S78–S90PubMed
33.
go back to reference Ananth CV et al (1999) Placental abruption and adverse perinatal outcomes. JAMA 282(17):1646–1651PubMed Ananth CV et al (1999) Placental abruption and adverse perinatal outcomes. JAMA 282(17):1646–1651PubMed
34.
go back to reference Zou G (2004) A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 159(7):702–706PubMed Zou G (2004) A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 159(7):702–706PubMed
35.
go back to reference Schluchter MD (2008) Flexible approaches to computing mediated effects in generalized linear models: generalized estimating equations and bootstrapping. Multivariate Behav Res 43(2):268–288PubMed Schluchter MD (2008) Flexible approaches to computing mediated effects in generalized linear models: generalized estimating equations and bootstrapping. Multivariate Behav Res 43(2):268–288PubMed
36.
go back to reference Bennedsen BE et al (1999) Preterm birth and intra-uterine growth retardation among children of women with schizophrenia. Br J Psychiatr 175:239–245 Bennedsen BE et al (1999) Preterm birth and intra-uterine growth retardation among children of women with schizophrenia. Br J Psychiatr 175:239–245
37.
go back to reference Bennedsen BE et al (2001) Obstetric complications in women with schizophrenia. Schizophr Res 47(2–3):167–175PubMed Bennedsen BE et al (2001) Obstetric complications in women with schizophrenia. Schizophr Res 47(2–3):167–175PubMed
38.
go back to reference Nilsson E et al (2002) Women with schizophrenia: pregnancy outcome and infant death among their offspring. Schizophr Res 58(2–3):221–229PubMed Nilsson E et al (2002) Women with schizophrenia: pregnancy outcome and infant death among their offspring. Schizophr Res 58(2–3):221–229PubMed
39.
go back to reference Zhong QY et al (2018) Adverse obstetric and neonatal outcomes complicated by psychosis among pregnant women in the United States. BMC Pregnancy Childbirth 18(1):120PubMedPubMedCentral Zhong QY et al (2018) Adverse obstetric and neonatal outcomes complicated by psychosis among pregnant women in the United States. BMC Pregnancy Childbirth 18(1):120PubMedPubMedCentral
40.
go back to reference Lee HC, Lin HC (2010) Maternal bipolar disorder increased low birthweight and preterm births: a nationwide population-based study. J Affect Disord 121(1–2):100–105PubMed Lee HC, Lin HC (2010) Maternal bipolar disorder increased low birthweight and preterm births: a nationwide population-based study. J Affect Disord 121(1–2):100–105PubMed
41.
go back to reference Nguyen TN et al (2013) Obstetric and neonatal outcomes of pregnant women with severe mental illness at a specialist antenatal clinic. Med J Aust 199(3 Suppl):S26–S29PubMed Nguyen TN et al (2013) Obstetric and neonatal outcomes of pregnant women with severe mental illness at a specialist antenatal clinic. Med J Aust 199(3 Suppl):S26–S29PubMed
42.
go back to reference Schneid-Kofman N, Sheiner E, Levy A (2008) Psychiatric illness and adverse pregnancy outcome. Int J Gynaecol Obstet 101(1):53–56PubMed Schneid-Kofman N, Sheiner E, Levy A (2008) Psychiatric illness and adverse pregnancy outcome. Int J Gynaecol Obstet 101(1):53–56PubMed
43.
go back to reference Vigod SN et al (2014) Maternal and newborn outcomes among women with schizophrenia: a retrospective population-based cohort study. BJOG 121(5):566–574PubMed Vigod SN et al (2014) Maternal and newborn outcomes among women with schizophrenia: a retrospective population-based cohort study. BJOG 121(5):566–574PubMed
44.
go back to reference Matevosyan NR (2011) Pregnancy and postpartum specifics in women with schizophrenia: a meta-study. Arch Gynecol Obstet 283(2):141–147PubMed Matevosyan NR (2011) Pregnancy and postpartum specifics in women with schizophrenia: a meta-study. Arch Gynecol Obstet 283(2):141–147PubMed
45.
go back to reference Simoila L et al (2018) Obstetric and perinatal health outcomes related to schizophrenia: a national register-based follow-up study among Finnish women born between 1965 and 1980 and their offspring. Eur Psychiatr 52:68–75 Simoila L et al (2018) Obstetric and perinatal health outcomes related to schizophrenia: a national register-based follow-up study among Finnish women born between 1965 and 1980 and their offspring. Eur Psychiatr 52:68–75
46.
go back to reference Jablensky AV et al (2005) Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatr 162(1):79–91PubMed Jablensky AV et al (2005) Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatr 162(1):79–91PubMed
47.
go back to reference Berger H et al (2016) Diabetes in pregnancy. J Obstet Gynaecol Can 38(7):667PubMed Berger H et al (2016) Diabetes in pregnancy. J Obstet Gynaecol Can 38(7):667PubMed
48.
go back to reference Butalia S et al (2018) Hypertension Canada’s 2018 guidelines for the management of hypertension in pregnancy. Can J Cardiol 34(5):526–531PubMed Butalia S et al (2018) Hypertension Canada’s 2018 guidelines for the management of hypertension in pregnancy. Can J Cardiol 34(5):526–531PubMed
49.
go back to reference Association A. D (2018) Management of diabetes in pregnancy. Diabetes Care 41(Suppl 1):S137–S143 Association A. D (2018) Management of diabetes in pregnancy. Diabetes Care 41(Suppl 1):S137–S143
50.
go back to reference Bérard A, Zhao JP, Sheehy O (2016) Success of smoking cessation interventions during pregnancy. Am J Obstet Gynecol 215(5):611.e1–611.e8 Bérard A, Zhao JP, Sheehy O (2016) Success of smoking cessation interventions during pregnancy. Am J Obstet Gynecol 215(5):611.e1–611.e8
51.
go back to reference Hand DJ et al (2017) Contingency management interventions for tobacco and other substance use disorders in pregnancy. Psychol Addict Behav 31(8):907–921PubMedPubMedCentral Hand DJ et al (2017) Contingency management interventions for tobacco and other substance use disorders in pregnancy. Psychol Addict Behav 31(8):907–921PubMedPubMedCentral
52.
go back to reference Oncken C et al (2008) Nicotine gum for pregnant smokers: a randomized controlled trial. Obstet Gynecol 112(4):859–867PubMedPubMedCentral Oncken C et al (2008) Nicotine gum for pregnant smokers: a randomized controlled trial. Obstet Gynecol 112(4):859–867PubMedPubMedCentral
53.
go back to reference Wisborg K et al (2000) Nicotine patches for pregnant smokers: a randomized controlled study. Obstet Gynecol 96(6):967–971PubMed Wisborg K et al (2000) Nicotine patches for pregnant smokers: a randomized controlled study. Obstet Gynecol 96(6):967–971PubMed
54.
go back to reference Kilbourne AM et al (2014) SMI life goals: description of a randomized trial of a collaborative care model to improve outcomes for persons with serious mental illness. Contemp Clin Trials 39(1):74–85PubMedPubMedCentral Kilbourne AM et al (2014) SMI life goals: description of a randomized trial of a collaborative care model to improve outcomes for persons with serious mental illness. Contemp Clin Trials 39(1):74–85PubMedPubMedCentral
55.
go back to reference Vaez K et al (2017) Evaluating diabetes care for patients with serious mental illness using the chronic care model: a pilot study. Health Serv Res Manag Epidemiol 4:2333392817734206PubMedPubMedCentral Vaez K et al (2017) Evaluating diabetes care for patients with serious mental illness using the chronic care model: a pilot study. Health Serv Res Manag Epidemiol 4:2333392817734206PubMedPubMedCentral
56.
go back to reference Dickerson F et al (2013) Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999-2011. Psychiatr Serv 64(1):44–50PubMed Dickerson F et al (2013) Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999-2011. Psychiatr Serv 64(1):44–50PubMed
57.
go back to reference Faulkner G, Cohn T, Remington G (2007) Interventions to reduce weight gain in schizophrenia. Cochrane Database Syst Rev 1:CD005148 Faulkner G, Cohn T, Remington G (2007) Interventions to reduce weight gain in schizophrenia. Cochrane Database Syst Rev 1:CD005148
58.
go back to reference Gilbody S et al (2015) Bespoke smoking cessation for people with severe mental ill health (SCIMITAR): a pilot randomised controlled trial. Lancet Psychiatr 2(5):395–402 Gilbody S et al (2015) Bespoke smoking cessation for people with severe mental ill health (SCIMITAR): a pilot randomised controlled trial. Lancet Psychiatr 2(5):395–402
59.
go back to reference Hauck Y et al (2008) Healthy babies for mothers with serious mental illness: a case management framework for mental health clinicians. Int J Ment Health Nurs 17(6):383–391PubMed Hauck Y et al (2008) Healthy babies for mothers with serious mental illness: a case management framework for mental health clinicians. Int J Ment Health Nurs 17(6):383–391PubMed
60.
go back to reference Tsoi DT, Porwal M, Webster AC (2013) Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev 2:CD007253 Tsoi DT, Porwal M, Webster AC (2013) Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev 2:CD007253
61.
go back to reference Bennett ME, Bradshaw KR, Catalano LT (2017) Treatment of substance use disorders in schizophrenia. Am J Drug Alcohol Abuse 43(4):377–390PubMed Bennett ME, Bradshaw KR, Catalano LT (2017) Treatment of substance use disorders in schizophrenia. Am J Drug Alcohol Abuse 43(4):377–390PubMed
62.
go back to reference Seeman MV (2008) Prevention inherent in services for women with schizophrenia. Can J Psychiatry 53(5):332–341PubMed Seeman MV (2008) Prevention inherent in services for women with schizophrenia. Can J Psychiatry 53(5):332–341PubMed
63.
go back to reference Hoirisch-Clapauch S, Nardi AE (2014) Markers of low activity of tissue plasminogen activator/plasmin are prevalent in schizophrenia patients. Schizophr Res 159(1):118–123PubMed Hoirisch-Clapauch S, Nardi AE (2014) Markers of low activity of tissue plasminogen activator/plasmin are prevalent in schizophrenia patients. Schizophr Res 159(1):118–123PubMed
64.
go back to reference Hoirisch-Clapauch S, Brenner B, Nardi AE (2015) Adverse obstetric and neonatal outcomes in women with mental disorders. Thromb Res 135(Suppl 1):S60–S63 Hoirisch-Clapauch S, Brenner B, Nardi AE (2015) Adverse obstetric and neonatal outcomes in women with mental disorders. Thromb Res 135(Suppl 1):S60–S63
65.
go back to reference Mittal VA, Ellman LM, Cannon TD (2008) Gene-environment interaction and covariation in schizophrenia: the role of obstetric complications. Schizophr Bull 34(6):1083–1094PubMedPubMedCentral Mittal VA, Ellman LM, Cannon TD (2008) Gene-environment interaction and covariation in schizophrenia: the role of obstetric complications. Schizophr Bull 34(6):1083–1094PubMedPubMedCentral
66.
go back to reference Suvisaari JM et al (2013) Obstetric complications as risk factors for schizophrenia spectrum psychoses in offspring of mothers with psychotic disorder. Schizophr Bull 39(5):1056–1066PubMed Suvisaari JM et al (2013) Obstetric complications as risk factors for schizophrenia spectrum psychoses in offspring of mothers with psychotic disorder. Schizophr Bull 39(5):1056–1066PubMed
67.
go back to reference Mei-Dan E, Ray JG, Vigod SN (2015) Perinatal outcomes among women with bipolar disorder: a population-based cohort study. Am J Obstet Gynecol 212(3):367e1–367e8 Mei-Dan E, Ray JG, Vigod SN (2015) Perinatal outcomes among women with bipolar disorder: a population-based cohort study. Am J Obstet Gynecol 212(3):367e1–367e8
Metadata
Title
Maternal schizophrenia and adverse birth outcomes: what mediates the risk?
Authors
Simone N. Vigod
Kinwah Fung
Abigail Amartey
Emily Bartsch
Reema Felemban
Natasha Saunders
Astrid Guttmann
Maria Chiu
Lucy C. Barker
Paul Kurdyak
Hilary K. Brown
Publication date
01-05-2020
Publisher
Springer Berlin Heidelberg
Published in
Social Psychiatry and Psychiatric Epidemiology / Issue 5/2020
Print ISSN: 0933-7954
Electronic ISSN: 1433-9285
DOI
https://doi.org/10.1007/s00127-019-01814-7

Other articles of this Issue 5/2020

Social Psychiatry and Psychiatric Epidemiology 5/2020 Go to the issue